Alcohol stocks after the selloff: why a 70% fall is not an investment thesis
Analysis as of October 10, 2026. Share-price comparisons use U.S. regular-session closing prices through October 9, 2026, in U.S. dollars.
Alcohol stocks can look tempting after a steep selloff, but the largest fall has not produced the lowest earnings multiple in this basket. Changing drinking habits, non-alcoholic expansion and luxury spending create different prospects for different producers. Before buying the dip or considering a short, compare sustainable earnings, cash flow and the stock’s response to news against its peers.
My concern is straightforward: an investor sees a stock down 60%, 70% or 80% and assumes the market has gone too far. Sometimes that creates an opportunity. Sometimes the market is adjusting to a business that will earn less than investors once expected.
A stock down 70% can still fall to 90% below its old high. And deciding not to buy it is a separate decision from deciding to short it.
The alcohol industry offers a useful case study because consumer behavior, company results and stock-market reactions tell different parts of the story.
Drinking habits are changing, but the Gen Z story needs updating
According to Gallup’s August 2026 survey, 54% of U.S. adults said they drink alcohol, matching the previous year’s record low. That compares with 62% in 2023. A majority, 51%, also viewed one or two alcoholic drinks a day as bad for health.
Young adults have participated in the decline. Gallup’s 2025 analysis found that reported drinking among Americans aged 18 to 34 fell from 59% in 2023 to 50% in 2025.
Actual sales volumes also show pressure. According to IWSR’s U.S. consumption report, total beverage alcohol volume fell 5% in 2025. Alcoholic beer and wine each declined 6%, while spirits fell 4%.
Internationally, IWSR reported a 2% decline in global beverage alcohol volume in 2025, the third consecutive annual fall. Separately, the International Organisation of Vine and Wine estimated that global wine consumption declined 2.7% to 208 million hectolitres, about 14% below 2018.
However, investors should update the assumption that younger people everywhere are steadily abandoning alcohol.
IWSR’s July 2026 consumer survey found that drinking participation among Gen Z consumers of legal drinking age across 15 markets stood at 74%, up from 66% three years earlier. Boomers had the lowest participation rate, at 71%.
The same survey found that drinking occasions were becoming less frequent and average drinks per occasion had fallen from 4.4 in 2024 and 2025 to 3.9 in the first half of 2026.
Gallup and IWSR use different questions, age definitions and samples. Their percentages should not be treated as interchangeable measurements, and a 15-market survey is not a census of the world.
The useful investment insight is that a company can retain its customers while losing some of their purchases. A consumer who still enjoys a drink but does so less often can create a meaningful revenue problem without becoming a non-drinker.
That makes drinking frequency and spending per occasion important alongside the number of people who drink.
Affordability matters too. IWSR’s U.S. report highlighted pressure on consumer budgets. Investors need to assess how much weakness could ease as household finances improve and how much reflects habits that may persist through a stronger economy.
A global recovery could still leave some alcohol consumer companies behind
Geography adds another layer.
In its June 2026 outlook, IWSR forecast that global alcohol volume would resume growth around 2031 and finish 2035 approximately 1% below 2025.
But its forecast for consumption measured in servings was far less favorable for some established markets: an 18% decline in the U.S. and a 14% decline in Germany between 2025 and 2035. India was forecast to grow 38% over that period.
These are forecasts, not established outcomes. Global beverage volume and national servings are also different measures.
The implication is still useful: a global industry that eventually stabilizes could contain companies exposed mainly to shrinking markets and others positioned to capture growth elsewhere.
An investor needs to know where the company’s profits come from, rather than assuming that a global brand has equally attractive exposure everywhere.
Six U.S.-listed alcohol companies worth comparing
This research basket includes four U.S.-based producers and two international groups accessible through U.S.-listed American depositary receipts, or ADRs. It represents different parts of the industry rather than six identical businesses.
Constellation Brands, NYSE: STZ
Constellation provides exposure to imported beer brands including Modelo, Corona and Pacifico in the U.S. Its October 6 fiscal second-quarter report showed beer net sales growth of 5% and shipment growth of 5.5%, while beer depletions fell 0.6%.
Depletions measure distributor sales to retailers, rather than purchases by the final consumer. The difference matters: higher shipments into distribution do not automatically establish stronger demand further along the chain.
Molson Coors, NYSE: TAP
The company behind Coors Light and Miller Lite offers a different view of beer demand. Its August 6 second-quarter results showed net sales down 3.3%, brand volume down 4.8% and underlying diluted earnings per share down 22.9%. Favorable pricing and product mix only partly offset lower volumes.
Brown-Forman, NYSE: BF.B
Brown-Forman’s brands include Jack Daniel’s and Woodford Reserve. Its September 2 fiscal first-quarter report showed organic net sales down 1%, but organic ready-to-drink sales up 11%. Management retained its forecast for approximately flat annual organic sales and a 3% to 5% decline in organic operating income.
Boston Beer, NYSE: SAM
Samuel Adams, Twisted Tea, Truly and Sun Cruiser make Boston Beer useful for studying changing tastes across beer and other alcoholic drinks. Its July 23 second-quarter report showed depletions down 6% and net revenue down 3.3%. Growth in Sun Cruiser and Angry Orchard partly offset declines elsewhere.
A supplier dispute also created a large difference between reported and adjusted earnings. Investors should review that exposure separately from the operating trend.
Diageo, NYSE: DEO, a U.S.-listed ADR
Diageo combines spirits brands including Johnnie Walker, Smirnoff and Don Julio with Guinness. Its August 6 full-year results showed organic net sales down 2%, comprising a 0.4% volume decline and a 1.6% unfavorable price/mix effect. Free cash flow nevertheless increased to approximately $3.2 billion.
AB InBev, NYSE: BUD, a U.S.-listed ADR
AB InBev owns a broad international portfolio including Budweiser, Stella Artois and Michelob Ultra. Its July 30 second-quarter results reported organic revenue growth of 5.6% and beer volume growth of 1.1%. No-alcohol beer revenue rose 27%.
One ownership distinction matters: Constellation holds the exclusive U.S. rights to Corona and Modelo. Investors should not confuse AB InBev’s international exposure to those brands with Constellation’s U.S. business.
“Organic” generally removes currency effects and changes in business ownership, although company definitions differ. These reports also cover different fiscal periods. They are evidence about business direction, not a perfectly standardized ranking.
Non-alcoholic drinks could change which companies benefit
A consumer who switches to alcohol-free beer may still buy from the same producer. Changing habits can therefore create an opportunity for companies that retain the spending occasion.
The question is which can build a meaningful, profitable business quickly enough to influence the group’s results.
AB InBev: measurable growth. Its Q2 2026 report showed no-alcohol beer revenue up 27% globally and growth in the mid-thirties in its U.S. portfolio, led by Michelob Ultra Zero.
Diageo: broader availability. Its 2026 annual report says non-alcoholic products reached 17 markets, up from 15. Guinness 0.0 delivered double-digit volume and net sales growth in Great Britain.
Molson Coors: a rollout to assess. A September 18 announcement outlined a nationwide U.S. rollout of Coors 0.0 and expanded national distributor availability for Naked Life in 2027. Planned distribution remains a future milestone rather than achieved sales.
Boston Beer: extending an established brand. Samuel Adams announced Non-Alcoholic Octoberfest in July 2026. A launch demonstrates adaptation, but does not establish a material contribution to earnings.
These disclosures cover different periods and measures, so they cannot fairly identify one winner. Compare growth, absolute sales, repeat purchases, market share and profit after production and marketing costs.
Consider a hypothetical company with $100 of revenue: $5 from non-alcoholic products and $95 from alcohol. If non-alcoholic sales grow 30% while alcohol sales fall 5%, total revenue becomes $96.75, down 3.25%.
Fast growth in a small business may still be insufficient to offset weakness in the larger one. Investors need evidence that expansion can become material and earn an acceptable return. Also remember that ready-to-drink products can contain alcohol; canned cocktail growth is not automatically alcohol-free growth.
Luxury alcohol has another demand cycle to watch
Prestige champagne, cognac and high-end spirits also belong in a luxury spending discussion. Weakness could reflect fewer drinking occasions, reduced willingness to spend on an expensive bottle, or both.
LVMH provides a bridge between fashion, champagne and cognac. Its January 2026 shareholder letter reported a 1% decline in group organic revenue and a 9% fall in recurring operating profit for 2025.
But its first-half 2026 results qualify a blanket decline thesis. Fashion and leather goods organic revenue fell 1% over the half, yet grew 1% in Q2. Wines and spirits organic revenue grew 5% over the half, with recurring operating profit up 11%.
Those are divisional figures, not standalone Louis Vuitton sales. They show why investors should update an old decline narrative when the evidence changes.
The market-data snapshot offers another qualification: Ralph Lauren’s reported trailing-year sales grew 14.7% and Tapestry’s grew 14.2%. Their shares gained approximately 15.0% and 2.4% over the year. They provide context about premium spending, rather than a benchmark for every luxury category.
A luxury recovery could support premium alcohol even while overall drinking volumes remain under pressure. That is a scenario to test, rather than a relationship that guarantees parallel stock returns.
Watch Chinese demand, tourism and travel retail, gifting, discounting, and the mix between expensive and lower-priced bottles. Do consumers drink less, trade down, or preserve purchases for special occasions?
When exposure warrants it, compare a premium alcohol company with a separate luxury group alongside its alcohol peers. A mainstream brewer has different demand drivers, and a diversified luxury group’s valuation does not directly value its drinks division.
The arithmetic behind the “this alcohol stock has fallen too far” trap
Consider a hypothetical stock that falls from $100 to $30. It is down 70%.
If it then falls to $10, it is down 90% from the original high. But the investor who bought at $30 has lost another 66.7%.
The old high offers no protection to the new buyer.
Valuation can be equally misleading. In another hypothetical example, a stock at $200 with $10 of annual earnings per share trades at 20 times earnings. If its price falls to $40 while earnings fall to $2, the shares have dropped 80% but still trade at 20 times earnings.
A lower share price has not created a lower earnings multiple.
Investors should also consider whether a slower-growing business deserves a lower multiple than it received during stronger years. Earnings can fall while the market reduces the price it will pay for each dollar of earnings.
A producer with modest growth could still offer attractive returns if its price adequately reflects the risks and its cash flow supports dividends, debt reduction or repurchases of undervalued shares. The investment case should work under conservative demand assumptions.
For related education, investingLive explains how earnings multiples, margins and growth fit together.
What the valuations reveal about this alcohol stock basket
The October 9 market-data snapshot places Boston Beer approximately 87.4% below its historical high, Brown-Forman 67.9% below and Molson Coors 66.8% below. Yet Boston Beer has the highest forward earnings multiple among the five companies with that estimate available in the snapshot.
The stock that has fallen furthest is not necessarily the cheapest on expected earnings.
Here is how the six businesses compare. Figures are rounded; forecast periods and accounting adjustments differ.
Molson Coors: the lowest multiples, with demand under pressure. At $37.20, the snapshot shows 7.8 times forward earnings, 5.3 times trailing free cash flow and 6.3 times enterprise value to EBITDA. The low valuation warrants investigation, alongside evidence that falling volumes and underlying earnings can stabilize.
Constellation: test the price against company guidance. At $122.64, trailing P/E is 11.0 and price/free cash flow is 11.3. Separately, management’s fiscal 2027 comparable EPS guidance of $11.20 to $11.90 gives a multiple of approximately 10.6 at the $11.55 midpoint. This uses adjusted guidance rather than the next-year consensus estimate used for other stocks.
Diageo: the earnings definition matters. At $86.73, forward P/E is 12.2 and price/free cash flow is 15.1, while trailing P/E is approximately 28.0. The gap needs an accounting explanation before it is treated as evidence of a dramatic operating recovery.
Brown-Forman: a large decline, with a higher multiple than Molson Coors. At $26.39, forward P/E is 15.4 and price/free cash flow is 13.2. Reported trailing-year sales were approximately flat. Do brand strength and future cash generation justify the earnings premium?
AB InBev: stronger recent evidence alongside a higher earnings multiple. At $77.33, forward P/E is 15.7, price/free cash flow is 9.9 and enterprise value to EBITDA is 9.4. Reported trailing-year sales grew 6.6%, while the shares gained 30.7% over the year. This distinguishes it from several peers, although past growth does not establish future returns.
Boston Beer: the deepest historical fall, with recovery still in expectations. At $170.51, forward P/E is 16.8, price/free cash flow is 8.5 and enterprise value to EBITDA is 7.9. Reported trailing-year sales fell 6.1%. Its different cash position and enterprise valuation also mean P/E alone cannot establish which stock is cheapest overall.
P/E divides price by earnings per share. Price/free cash flow compares equity value with cash generated after capital expenditure. Enterprise value to EBITDA includes debt and other capital claims, and compares that value with earnings before interest, taxes, depreciation and amortization. EBITDA does not deduct the capital spending needed to maintain the business.
Check the earnings definition before ranking bargains
Molson Coors’ trailing loss includes the period containing its approximately $3.65 billion goodwill impairment in Q3 2025. The write-down does not create an equivalent cash outflow when booked, but signals reduced expectations about asset value.
Boston Beer’s 2026 guidance forecasts a GAAP loss of $4.23 to $6.23 per share, yet adjusted earnings of $8.50 to $10.50 after excluding supplier litigation effects. The legal exposure remains relevant.
Diageo’s fiscal 2026 results show EPS before exceptional items approximately twice reported EPS. This helps explain its trailing/forward multiple gap. Its U.S. depositary shares represent four ordinary shares each, so independent calculations must match the share basis and currency.
Compare historical cash flow with the outlook
Molson Coors’ snapshot multiple implies a historical cash-flow yield of approximately 19.0%. But its 2026 underlying free cash flow guidance midpoint of $1.1 billion, divided by the snapshot equity value of $6.99 billion, gives approximately 15.7%.
For Constellation, the equivalent historical yield is approximately 8.9%. Its fiscal 2027 free cash flow guidance midpoint of $1.65 billion, divided by the snapshot equity value of $20.75 billion, gives approximately 8.0%.
These ratios are not promised returns or dividend yields. Company guidance and historical vendor figures can use different adjustments. The comparison identifies what to reconcile and whether the apparent cash valuation survives a more forward-looking test.
Lower the earnings assumption before deciding the alcohol stock is cheap
Holding prices unchanged, a hypothetical 20% reduction in the earnings used above raises Molson Coors’ multiple from 7.8 to 9.7, Constellation’s guidance-based multiple from 10.6 to 13.3, and Boston Beer’s forward multiple from 16.8 to 21.0.
This is a sensitivity test, not a forecast. Debt, brand quality and the likelihood of continued deterioration still matter. The market could also reduce the multiple it assigns to those earnings.
Compare the earnings reactions of alcohol stocks using the same clock
For investors considering a short, a declining industry is only the beginning of the analysis.
The market also compares results with expectations. Falling sales can accompany a rally if investors feared a worse outcome. Check changes in forward guidance and earnings expectations alongside the headline results.
A useful additional question is: when comparable stocks receive a reason to rally, does this company participate?
Two comparisons help answer it.
Compare the same calendar dates. Measure the company, its peers and a broad market benchmark over the same period. This helps distinguish company weakness from a market-wide decline.
Compare the same number of sessions after earnings. Begin at the last regular-session close before the announcement, then compare performance after one, five and 20 trading sessions. For a release after the close, the announcement day’s close is the starting point. For a release before the open, use the previous session’s close.
Where possible, choose companies reporting within the same earnings wave. Comparing one stock three sessions after results with another two months after results creates an unequal test.
An easy way to visualize the comparison is to start every stock at 100 before its announcement. Compare percentage changes rather than dollar changes. Keep the company being assessed out of its own peer benchmark. For longer-term investment performance, include dividends in a separate total-return comparison.
A same-day example: Molson Coors and Diageo
Molson Coors and Diageo both released results before the U.S. regular session on August 6, 2026. Starting from their August 5 closing prices gives a clean timing comparison.
Molson Coors, TAP: +1.3% after the first session; -0.7% after the fifth; -11.2% through October 9.
Diageo ADR, DEO: +4.9% after the first session; +6.3% after the fifth; -1.9% through October 9.
S&P 500 ETF, SPY: -0.2% after the first session; +0.4% after the fifth; +1.1% through October 9.
Calculated from historical closing prices for TAP, DEO and SPY. All changes use August 5 as the baseline. The first session ends August 6; the fifth ends August 12. These are price changes, excluding dividends.
Both alcohol stocks initially rose. By October 9, both were below their pre-report prices, with Molson Coors performing worse. The broader market was slightly higher.
That is useful evidence about how much of the initial optimism survived. It does not establish that changing drinking habits caused every subsequent move.
Diageo also held a capital markets day on August 6, and Molson Coors left the S&P 500 effective September 21. Those additional developments belong in the interpretation.
Beer and spirits are also different businesses. Equal announcement timing improves the comparison, but investors should still compare each company with its closest operating peers.
Just as one example of many, here is how the downtrend looks like on a monthly stock price chart…
Diageo (NYSE: DEO): A recovery attempt within a persistent downtrend
Diageo, the global spirits producer behind Johnnie Walker, Tanqueray, Smirnoff and Guinness, continues to show a bearish long-term technical picture despite recovering from its 2026 lows.
The monthly chart tells the story. After peaking near $198 in early 2022, Diageo entered a prolonged decline, losing more than 55% of its value by the October 2026 snapshot. The stock is trading around $87, with a succession of lower highs and lower lows establishing a clear downward trend.
Importantly, DEO remains below its declining 20-month exponential moving average (EMA), currently near $94. That means the recent improvement in price has not yet been sufficient to change the broader technical assessment.
There are three areas worth watching:
-
$93-$95: First recovery test.This is where the declining monthly moving average sits. A monthly close above this area, followed by sustained trading above it, would suggest that the recovery is becoming more credible. A rejection would instead reinforce the existing bearish structure.
-
$100-$107: A more significant recovery hurdle.This region contains earlier trading activity and potential overhead resistance. Reclaiming it would improve the case that DEO is moving beyond a temporary bounce, although it would not automatically restore the longer-term uptrend.
-
$72-$76: Downside reference area.The stock’s 2026 low was around $72. A retreat toward this region would put the recent recovery under pressure. A completed monthly break below the previous low would strengthen the bearish continuation scenario.
One interesting feature is that the stock has already rebounded considerably from its lows, yet the longer-term moving average continues to decline. This illustrates an important distinction between a recovery in price and an actual change in trend.
For investors considering whether the substantial decline represents an opportunity, the chart provides a useful reason for patience. A stock can become much cheaper than it was several years ago while remaining technically weak.
The takeaway:Diageo is showing early signs of stabilization, but the monthly chart has not confirmed a bullish reversal. The first meaningful test is whether buyers can reclaim the $93-$95 area and defend it, rather than allowing another recovery attempt to fail.
Chart reference: Diageo plc (NYSE: DEO), monthly timeframe, October 2026 snapshot. Price zones are approximate and are not trading instructions.
How about to just sell short that declining alcohol stock? A fresh example that challenges an automatic short
Constellation reported after the close on October 6. Its October 6 close therefore provides the pre-announcement anchor.
Across the next three U.S. sessions, the basket behaved as follows:
Constellation, STZ: +6.0%. It led this basket over the three-session window.
Peer changes: AB InBev and Diageo each gained approximately 2.3%; Molson Coors gained 0.8%; Brown-Forman gained 0.2%; Boston Beer gained 0.1%.
Market comparison: SPY declined approximately 0.1%.
Calculated from October 6 and October 9 regular-session closes in the linked histories for STZ, BUD, DEO, TAP, BF.B, SAM and SPY. Dividends are excluded. This is a common calendar window around Constellation’s report; the other companies did not all announce earnings during it.
Constellation rose from $115.67 to $122.64 and outperformed every other stock in this basket. Its report also included the acquisition of ready-to-drink brand SpikedAde, so the period captures more than the quarterly numbers alone.
The interpretation is that Constellation showed relative strength after its latest announcement. That weakens a short thesis based simply on the idea that alcohol consumption is declining.
Three sessions cannot establish a lasting recovery. The next question is whether that strength persists as investors assess demand and future earnings.
What deserves attention before buying or shorting an alcohol stock
Look beyond shipments to repeat demand.
Track depletions, retail sales and comparable volume trends where disclosed. A distributor replenishing stock can help one quarter without establishing a lasting increase in consumption.
Check whether pricing is protecting profits.
Higher prices or a shift toward more expensive products can support revenue while volumes fall. Examine promotional spending and margins to judge whether that support is durable.
Test cash flow and debt alongside the dividend.
Free cash flow is the cash left after capital expenditure. Compare it with dividends and the company’s debt obligations. A rising dividend yield caused by a falling share price does not improve the company’s capacity to pay it.
Define what would change the thesis.
For a prospective buyer, useful evidence might include stabilizing underlying demand, sustainable cash generation and earnings expectations that stop deteriorating.
For a prospective short seller, repeated failure to participate in peer rallies would justify closer investigation, especially alongside weaker guidance or worsening demand. Stronger demand and persistent outperformance after results would weaken that bearish interpretation.
A favorable peer event could be improved demand guidance, lower input costs or reduced tariff pressure. Observe whether the event is relevant to the company being assessed before treating its response as meaningful.
Short sellers must also account for borrowing costs, dividend payments and the possibility of theoretically unlimited losses, as explained in the SEC’s short-selling bulletin.
The question for an alcohol-stock investor is what level of future earnings the current price can reasonably support. For a short seller, the question includes what could force expectations lower, and what evidence would show the bearish case is failing.
Neither question is answered by the distance from an old high.
Educational analysis. Trading and investing involve risk of loss.
I am also watching… Mag 7 technicals, Delta’s demand and fuel costs, Trump’s Nvidia disclosures and OpenAI’s revenue figures. Take a look.
This article was written by Itai Levitan at investinglive.com.